Beyond Air (XAIR) Income from Non-Controlling Interests (2021 - 2026)
Beyond Air's (XAIR) quarterly Income from Non-Controlling Interests came in at -$219000.0 in Q2 2026, up 43.41% year-over-year from -$152708.1 in Q2 2025, and down 154.65% quarter-over-quarter from -$86000.0 in Q1 2026.
Powered by 
Analysis
Beyond Air (XAIR) Income from Non-Controlling Interests (2021 - 2026) Analysis & Trends
Beyond Air has disclosed Income from Non-Controlling Interests across 6 years of filings, most recently posting -$219000.0 for Q2 2026.
- In Q2 2026, Income from Non-Controlling Interests rose 43.41% year-over-year to -$219000.0; the TTM figure through Jun 2026 stood at -$917000.0 (up 33.89% YoY), while the FY2026 annual figure was -$1.1 million, up 41.48% from the prior year.
- Income from Non-Controlling Interests came in at -$219000.0 for Q2 2026 at Beyond Air, down from -$86000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of -$29000.0 in Q1 2025 to a low of -$1.2 million in Q3 2023.
- Average Income from Non-Controlling Interests over 5 years is -$636333.3, with a median of -$695500.0 recorded in 2022.
- Year-over-year, Income from Non-Controlling Interests slumped 371.3% in 2022 and surged 96.58% in 2025.
- Over 5 years, Income from Non-Controlling Interests stood at -$1.1 million in 2022, then rose by 1.24% to -$1.0 million in 2023, then surged by 71.1% to -$300000.0 in 2024, then advanced by 2.0% to -$294000.0 in 2025, then grew by 25.51% to -$219000.0 in 2026.
- Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were -$219000.0 in Q2 2026, -$86000.0 in Q1 2026, and -$294000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.57 Bn | 174.97 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.64 Bn | 122.42 Bn | 1.96 Bn | 6.60 Mn |
| 3 | Medtronic | 116.77 Bn | 107.95 Bn | 6.34 Bn | 9.00 Mn |
| 4 | Stryker | 103.85 Bn | 100.38 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.48 Bn | 62.94 Bn | 3.85 Bn | -2.00 Mn |
| 6 | Edwards Lifesciences | 49.82 Bn | 45.56 Bn | 1.35 Bn | -500,000.00 |
| 7 | Alcon | 32.97 Bn | 31.51 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.09 Bn | 30.14 Bn | 830.00 Mn | - |
| 9 | Steris | 20.68 Bn | 20.20 Bn | 684.20 Mn | 900,000.00 |
| 10 | Beyond Air | 2.24 Mn | -8.68 Mn | 225,000.00 | -219,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -219,000.00 |
| Mar 31, 2026 | -86,000.00 |
| Dec 31, 2025 | -294,000.00 |
| Sep 30, 2025 | -318,000.00 |
| Jun 30, 2025 | -387,000.00 |
| Mar 31, 2025 | -29,000.00 |
| Dec 31, 2024 | -300,000.00 |
| Sep 30, 2024 | -671,000.00 |
| Jun 30, 2024 | -854,000.00 |
| Mar 31, 2024 | -849,000.00 |
| Dec 31, 2023 | -1.04 Mn |
| Sep 30, 2023 | -1.21 Mn |
| Jun 30, 2023 | -960,000.00 |
| Mar 31, 2023 | -984,000.00 |
| Dec 31, 2022 | -1.05 Mn |
| Sep 30, 2022 | -830,000.00 |
| Jun 30, 2022 | -720,000.00 |
| Mar 31, 2022 | -659,000.00 |
| Dec 31, 2021 | -223,000.00 |